Medication induced diabetes during induction in pediatric acute lymphoblastic leukemia: prevalence, risk factors and characteristics

Abstract

Medication induced diabetes (MID) during induction therapy (MIDi) in patients with acute lymphoblastic leukemia (ALL) is not well characterized in children, with recent studies yielding conflicting results. The purpose of the study was to describe the prevalence of MIDi and risk factors for its development. We retrospectively gathered demographic, disease… (More)
DOI: 10.1007/s00520-011-1307-5

Topics

3 Figures and Tables

Slides referencing similar topics